It wouldn’t be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets. In fact, he still wields a scalpel quite frequently, and on this episode of the Business of Biotech podcast, he offers a fantastic reason why. Yes, it’s a bit of a departure from our normal routine of biotech founders occupying the guest chair. But, Pashazadeh’s no-holds-barred reflections on and analysis of biotech breaking points, drawn from more than 2 decades of troubleshooting broken bipharmaceutical businesses and correcting courses, makes for some great programming. Whether you’re a biotech builder in the throes of disruption, or feeling lucky that you’ve been threading scientific, clinical, capital, and regulatory needles all along, this episode offers a ton of insight from the unwritten textbooks on the business of biotech.
For the full article, please continue reading at Bioprocess Online: https://www.bioprocessonline.com/doc/biotech-course-correction-with-treehill-partners-ali-pashazadeh-0001
For excerpts from the videos, watch on YouTube:
https://www.youtube.com/watch?v=xF3jtSWxvTg
https://www.youtube.com/watch?v=ngFba0paMuY
https://www.youtube.com/watch?v=QLt99ssTY84